| Name | 2,3-Dimethoxy-5-((trimethylsilyl)ethynyl)pyridine |
|---|---|
| Synonyms |
4-Nitro-2,3-dimethoxybenzoesaeure
Benzoic acid,2,3-dimethoxy-4-nitro 2,3-Dimethoxy-4-nitro-benzoesaeure 2,3-dimethoxy-4-nitro-benzoic acid 4-Nitro-2.3-dimthoxy-benzoesaeure 2,3-dimethoxy-5-[(trimethylsilyl)ethynyl]pyridine |
| Molecular Formula | C12H17NO2Si |
|---|---|
| Molecular Weight | 235.35400 |
| Exact Mass | 235.10300 |
| PSA | 31.35000 |
| LogP | 2.32770 |
|
~72%
1171919-88-2 |
| Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED; FARNABY, William; FIELDHOUSE, Charlotte; KERR, Catrina; KINSELLA, Natasha; LIVERMORE, David; MERCHANT, Kevin; MILLER, David; HAZEL, Katherine Patent: WO2013/4996 A1, 2013 ; Location in patent: Page/Page column 49 ; WO 2013/004996 A1 |
|
~%
1171919-88-2 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: US2011/81316 A1, 2011 ; |
|
~%
1171919-88-2 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: US2011/81316 A1, 2011 ; |
|
~%
1171919-88-2 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: US2011/81316 A1, 2011 ; |
|
~%
1171919-88-2 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: US2011/81316 A1, 2011 ; |
| Precursor 6 | |
|---|---|
| DownStream 0 | |